Published in Eur J Heart Fail on June 01, 1999
Assessing the impact of heart failure specialist services on patient populations. BMC Health Serv Res (2004) 0.84
A comparison of a low-dose warfarin induction regimen with the modified Fennerty regimen in elderly inpatients. Age Ageing (2000) 3.35
Hyperkalaemic cardiac arrhythmia caused by potassium citrate mixture. Br Med J (Clin Res Ed) (1981) 3.20
Anxiety and depression in patients with chest pain referred for exercise testing. Lancet (1985) 2.85
Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. Eur Heart J (2000) 2.85
Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol (2006) 2.46
Managing atrial fibrillation in elderly people. BMJ (1999) 1.92
Snow shoveller's infarction. BMJ (1991) 1.74
Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study. Circulation (2000) 1.71
The triad of erectile dysfunction, hypogonadism and the metabolic syndrome. Int J Clin Pract (2008) 1.69
Effect of treatment of carotid artery stenosis on blood pressure: a comparison of hemodynamic disturbances after carotid endarterectomy and endovascular treatment. Stroke (2003) 1.64
Novel platelet membrane glycoprotein VI dimorphism is a risk factor for myocardial infarction. Circulation (2001) 1.61
Deciding who should have thrombolysis. BMJ (1993) 1.59
Androgens, insulin resistance and vascular disease in men. Clin Endocrinol (Oxf) (2005) 1.58
Increasing prescription of drugs for secondary prevention after myocardial infarction. BMJ (1995) 1.57
Reporting on reports--cardiological intervention in elderly patients. J R Coll Physicians Lond (1995) 1.49
Pitfalls and problems of relying on serum troponin. QJM (2005) 1.45
How important is family history in ischaemic heart disease? QJM (1997) 1.41
Unsatisfactory management of patients with myocardial infarction admitted to general medical wards. J R Coll Physicians Lond (1994) 1.40
Junior doctors and the full shift rota--psychological and hormonal changes: a comparative cross-sectional study. Clin Med (2006) 1.40
Effect of posture and drink volume on the swallowing of capsules. Br Med J (Clin Res Ed) (1982) 1.38
The effect of meals of differing composition on exercise tolerance in patients with angina pectoris. Eur Heart J (1996) 1.38
Overdiagnosis of infective endocarditis. Lancet (1988) 1.38
Tetracycline-induced oesophageal ulceration. Br Med J (Clin Res Ed) (1981) 1.37
The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes. Eur J Endocrinol (2007) 1.30
Gender differences in the vasomotor effects of different steroid hormones in rat pulmonary and coronary arteries. Horm Metab Res (2001) 1.28
Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life. Heart (2004) 1.22
Evaluation of a protocol to select patients of all ages for cardioversion from atrial fibrillation. Age Ageing (1997) 1.16
The normal range for inter-arm differences in blood pressure. Age Ageing (1999) 1.14
Drug treatment in heart failure. BMJ (1998) 1.14
Testosterone as a protective factor against atherosclerosis--immunomodulation and influence upon plaque development and stability. J Endocrinol (2003) 1.12
A new regimen for starting warfarin therapy in out-patients. Br J Clin Pharmacol (1998) 1.12
Testosterone treatment for men with chronic heart failure. Heart (2004) 1.09
Changes in haemodynamic variables during transurethral resection of the prostate: comparison of general and spinal anaesthesia. Br J Anaesth (1994) 1.08
An evaluation of the effects of Tai Chi Chuan and Chi Kung training in patients with symptomatic heart failure: a randomised controlled pilot study. Postgrad Med J (2007) 1.07
Androgen receptor CAG repeat polymorphism is associated with serum testosterone levels, obesity and serum leptin in men with type 2 diabetes. Eur J Endocrinol (2008) 1.06
Estimation of left ventricular end-diastolic pressure by pulsed Doppler ultrasound. Lancet (1986) 1.05
Erectile dysfunction is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 diabetes. Int J Androl (2007) 1.05
The effect of hyoscine butylbromide on the swallowing of capsules. Br J Clin Pharmacol (1983) 1.05
Improving the interpretation of electrocardiographs in an accident and emergency department. Postgrad Med J (1995) 1.03
Towards improved control of atrial fibrillation. Eur Heart J (1987) 1.03
Spontaneous iliopsoas haemorrhage--an unusual complication of streptokinase therapy. Postgrad Med J (1990) 0.99
Endocarditis prophylaxis: do patients remember advice and know what to do? Br Med J (Clin Res Ed) (1986) 0.99
Testosterone acts as a coronary vasodilator by a calcium antagonistic action. J Endocrinol Invest (2002) 0.98
Selective inhibition of L-type Ca2+ channels in A7r5 cells by physiological levels of testosterone. Endocrinology (2006) 0.98
Prognostic implications of qualitative assessment of left ventricular function compared to simple routine quantitative echocardiography. Heart (1997) 0.96
Choosing drugs for secondary prevention after myocardial infarction: a pragmatic approach. Postgrad Med J (1995) 0.95
Inverse relationship between serum levels of interleukin-1beta and testosterone in men with stable coronary artery disease. Horm Metab Res (2007) 0.94
Cardiovascular effects of testosterone: implications of the "male menopause"? Heart (2003) 0.92
Improved control of atrial fibrillation with combined pindolol and digoxin therapy. Eur Heart J (1989) 0.92
Aging reduces the responsiveness of coronary arteries from male Wistar rats to the vasodilatory action of testosterone. Clin Sci (Lond) (2000) 0.89
Testosterone acts as an efficacious vasodilator in isolated human pulmonary arteries and veins: evidence for a biphasic effect at physiological and supra-physiological concentrations. J Endocrinol Invest (2009) 0.88
Antipyrine absorption after delayed oesophageal capsule transit. Br J Clin Pharmacol (1984) 0.88
A breathless triathlete. Lancet (2002) 0.86
Thiazides with loop diuretics for severe congestive heart failure. Lancet (1990) 0.86
Effect of the calcium antagonist amlodipine on the two phases of hypoxic pulmonary vasoconstriction in rat large and small isolated pulmonary arteries. J Cardiovasc Pharmacol (1995) 0.86
Platelet glycoprotein IIIa gene polymorphism and myocardial infarction. Lancet (1996) 0.85
The effect of posture at the time of administration on the central depressant effects of the new hypnotic zopiclone. Br J Clin Pharmacol (1984) 0.85
Oesophageal abnormalities in patients with chest pain. Lancet (1986) 0.84
The influence of sex hormones on pulmonary vascular reactivity: possible vasodilator therapies for the treatment of pulmonary hypertension. Curr Vasc Pharmacol (2006) 0.84
Testosterone for secondary prevention in men with ischaemic heart disease? QJM (2003) 0.84
Vasodilatory action of the calcium antagonist amlodipine on large and resistance pulmonary arteries from normoxic and chronically hypoxic rats. Clin Sci (Lond) (1993) 0.83
Effect of cigarette smoking on levels of bioavailable testosterone in healthy men. Clin Sci (Lond) (2001) 0.83
The effect of size and shape of tablets on their esophageal transit. J Clin Pharmacol (1986) 0.82
Testosterone and coronary heart disease: is there a link? QJM (1997) 0.82
The effect of formulation on oesophageal transit. J Pharm Pharmacol (1985) 0.82
Testosterone: a natural tonic for the failing heart? QJM (2000) 0.82
Assessment of the value of technician reporting of electrocardiographs in an accident and emergency department. J Accid Emerg Med (1997) 0.81
Response of normoxic pulmonary arteries of the rat in the resting and contracted state to NO synthase blockade. Br J Pharmacol (1997) 0.81
Monitoring patients with left ventricular failure by electrical impedance tomography. Eur J Heart Fail (1999) 0.80
The -1185 A/G and -1051 G/A dimorphisms in the von Willebrand factor gene promoter and risk of myocardial infarction. Br J Haematol (2001) 0.80
Open access echocardiography. Open access to specialist opinion is preferable. BMJ (1995) 0.80
Acute pulmonary vasodilatory properties of amlodipine in humans with pulmonary hypertension. Heart (1996) 0.80
Kozak sequence polymorphism in the platelet GPIbalpha gene is not associated with risk of myocardial infarction. Blood (2000) 0.80
Oesophageal function in diabetes mellitus and its association with autonomic neuropathy. Diabet Med (1985) 0.79
Testosterone does not adversely affect fibrinogen or tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1) levels in 46 men with chronic stable angina. Eur J Endocrinol (2005) 0.79
An open label, randomised, crossover study comparing sotalol and atenolol in the treatment of symptomatic paroxysmal atrial fibrillation. Heart (1999) 0.79
Dyslipidaemia is associated with testosterone, oestradiol and androgen receptor CAG repeat polymorphism in men with type 2 diabetes. Clin Endocrinol (Oxf) (2011) 0.79
Pulmonary embolism presenting with atrial fibrillation. Lancet (1993) 0.78
Depression: the sleeping giant. Eur Heart J (2000) 0.78
The prothrombin 20210A allele and its association with myocardial infarction. Thromb Haemost (1999) 0.78
Subcutaneous versus intravenous administration of heparin in the treatment of deep vein thrombosis; which do patients prefer? A randomized cross-over study. Postgrad Med J (1993) 0.78
Doppler measurement of cardiac output during cardiopulmonary resuscitation. J Accid Emerg Med (1996) 0.78
The role of vasopressin in cardiorespiratory arrest and pulmonary hypertension. QJM (2006) 0.78
Translating clinical trials into practice. Lancet (1997) 0.78
Persistent visual hallucinations secondary to chronic solvent encephalopathy: case report and review of the literature. J Neurol Neurosurg Psychiatry (1983) 0.77
Analysis of the postulated interaction between the angiotensin II sub-type 1 receptor gene A1166C polymorphism and the insertion/deletion polymorphism of the angiotensin converting enzyme gene on risk of myocardial infarction. Atherosclerosis (2001) 0.77
Integration between general and geriatric medicine: a needs related policy. J R Coll Physicians Lond (1995) 0.77
The GPIa C807T dimorphism associated with platelet collagen receptor density is not a risk factor for myocardial infarction. Br J Haematol (1999) 0.77
Hypoxaemia and supplemental oxygen therapy in the first 24 hours after myocardial infarction: the role of pulse oximetry. J R Coll Physicians Lond (1998) 0.77
An evaluation and improvement program for inpatient anticoagulant control. Thromb Haemost (1997) 0.77
Intravenous enoximone or dobutamine for severe heart failure after acute myocardial infarction: a randomized double-blind trial. Eur Heart J (1993) 0.77
Xamoterol improves the control of chronic atrial fibrillation in elderly patients. Age Ageing (1995) 0.77
The role of androgen receptor CAG repeat polymorphism and other factors which affect the clinical response to testosterone replacement in metabolic syndrome and type 2 diabetes: TIMES2 sub-study. Eur J Endocrinol (2013) 0.77
Effect of delayed esophageal transit on acetaminophen absorption. Clin Pharmacol Ther (1985) 0.76
Amlodipine in patients with angina uncontrolled by atenolol. A double blind placebo controlled cross over trial. Eur J Clin Pharmacol (1993) 0.76
Heart failure: vive la difference! Heart (1997) 0.76